Page last updated: 2024-09-05

eslicarbazepine acetate and Alzheimer Disease

eslicarbazepine acetate has been researched along with Alzheimer Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biswas, D; Hameed, N; Kamal, MA; Khan, M; Rizvi, SM; Shaikh, S; Shakil, S	1

Other Studies

1 other study(ies) available for eslicarbazepine acetate and Alzheimer Disease

Article	Year
Aptiom (eslicarbazepine acetate) as a dual inhibitor of β-secretase and voltage-gated sodium channel: advancement in Alzheimer's disease-epilepsy linkage via an enzoinformatics study. CNS & neurological disorders drug targets, 2014, Volume: 13, Issue:7 Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Dibenzazepines; Epilepsy; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Molecular Structure; Protease Inhibitors; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels	2014

Article

Year

Aptiom (eslicarbazepine acetate) as a dual inhibitor of β-secretase and voltage-gated sodium channel: advancement in Alzheimer's disease-epilepsy linkage via an enzoinformatics study.

CNS & neurological disorders drug targets, 2014, Volume: 13, Issue:7

Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Dibenzazepines; Epilepsy; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Molecular Structure; Protease Inhibitors; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels

2014